Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Short Interest Update

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Rating) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 238,700 shares, a growth of 50.8% from the March 31st total of 158,300 shares. Based on an average daily volume of 215,100 shares, the days-to-cover ratio is […]

Related Keywords

,Corvus Pharmaceuticals Inc ,News Ratings For Corvus Pharmaceuticals Daily ,Corvus Pharmaceuticals ,Renaissance Technologies ,Institutional Trading Of Corvus Pharmaceuticals ,Acadian Asset Management ,Bailard Inc ,Nasdaq ,Corvus Pharmaceuticals Price Performance ,Vanguard Group Inc ,Get Rating ,Asset Management ,Street Corp ,Adenosine Production Inhibitor ,Corvus Pharmaceuticals Daily ,Nasdaq Crvs ,Ccrvs ,Medical ,Stocks ,Options ,Put ,Call ,